Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions

A method for treating pancreatogenic diabetes (or Type 3c diabetes milieus) in a subject in need thereof comprising using a composition comprising compounds with a formula of

• wherein
• R2 and R4 are each independently selected from —OR11 and —OC(O)R11;
• R1, R3, R5, R6, R7, R8, R9 and R10 are each independently selected from hydrogen, halogen, trifluoromethyl, —OR11 and —OC(O)R11;
• or R2 and R3, or R7 and R8 are taken together with the carbon atoms to which they are attached to form a cyclic group;
• R11 is independently hydrogen or selected from hydrocarbyl and heterocyclyl, either of which is optionally substituted with 1, 2, 3, 4 or 5 R12;
• R12 is independently selected from halogen, trifluoromethyl, cyano, nitro, oxo, —OR13, —C(O)R14, —C(O)N(R13)R14, —C(O)OR13, —OC(O)R14, —S(O)2R13, —S(O)2N(R13)R14, —N(R13)R14;
• R13 and R14 are each independently hydrogen or selected from hydrocarbyl and heterocyclyl, either of which is optionally substituted with 1, 2, 3, 4 or 5 substituents independently selected from halogen, cyano, amino, hydroxy, C1-6 alkyl and C1-6 alkoxy;
• or an enantiomer thereof;
• or a pharmaceutically acceptable salt or prodrug thereof;
• or a mixture of said compound, the derivative and/or chemical variants thereof.